Nanotechnology: a promising approach for delivery of neuroprotective drugs

S Naqvi, A Panghal, SJS Flora - Frontiers in Neuroscience, 2020 - frontiersin.org
Central nervous system (CNS) disorders especially neurodegenerative disorders are the
major challenge for public health and demand the great attention of researchers to protect …

Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours

J Garg, K Pathania, SP Sah, SV Pawar - Future Journal of Pharmaceutical …, 2022 - Springer
Background In recent years, the field of nanotechnology and nanomedicine has transformed
the pharmaceutical industry with the development of novel drug delivery systems that …

Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: at a glance

MM Rhaman, MR Islam, S Akash, M Mim… - Frontiers in Cell and …, 2022 - frontiersin.org
In recent decades, research scientists, molecular biologists, and pharmacologists have
placed a strong emphasis on cutting-edge nanostructured materials technologies to …

Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases

A Chowdhury, S Kunjiappan, T Panneerselvam… - International nano …, 2017 - Springer
Degenerative diseases are results of deterioration of cells and tissues with aging either by
unhealthy lifestyle or normal senescence. The degenerative disease likely affects central …

Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines

J Wang, X Hu, D Xiang - Drug delivery, 2018 - Taylor & Francis
In the past 40 years, the nanoparticle drug delivery system for tumor peptide vaccines has
been widely studied which also reached a splendid result. Nanomaterial can enhance the …

Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery

PEC Leite, MR Pereira, G Harris, D Pamies… - Particle and fibre …, 2019 - Springer
Background The blood brain barrier (BBB) is the bottleneck of brain-targeted drug
development. Due to their physico-chemical properties, nanoparticles (NP) can cross the …

[HTML][HTML] Nanomedicine in central nervous system (CNS) disorders: a present and future prospective

S Soni, RK Ruhela, B Medhi - Advanced pharmaceutical bulletin, 2016 - ncbi.nlm.nih.gov
Purpose: For the past few decades central nervous system disorders were considered as a
major strike on human health and social system of developing countries. The natural …

Emerging nanoformulations for drug targeting to brain through intranasal delivery: A comprehensive review

S Bahadur, MK Jha - Journal of Drug Delivery Science and Technology, 2022 - Elsevier
The blood-brain barrier (BBB) has a very significant role in drug delivery to the brain, which
allows passes of only a few molecules. Conventional drug delivery systems have very …

[HTML][HTML] Liposomes for drug delivery in stroke

GE Bruch, LF Fernandes, BLT Bassi, MTR Alves… - Brain research …, 2019 - Elsevier
Stroke is one of the leading causes of mortality and morbidity worldwide. Due to its poor
prognosis, there is a major negative impact on the patients and their family's life quality …

Transferrin-Enabled Blood–Brain Barrier Crossing Manganese-Based Nanozyme for Rebalancing the Reactive Oxygen Species Level in Ischemic Stroke

Q Zhao, W Du, L Zhou, J Wu, X Zhang, X Wei, S Wang… - Pharmaceutics, 2022 - mdpi.com
(1) Background: Acute ischemic stroke (IS) is one of the main causes of human disability and
death. Therefore, multifunctional nanosystems that effectively cross the blood–brain barrier …